chapter
describ
develop
recombin
measl
viru
mv
base
vaccin
start
plasmid
dna
liveattenu
measl
vaccin
effici
safe
sinc
avail
revers
genet
system
manipul
mv
genom
gener
respect
recombin
virus
consider
number
recombin
virus
gener
present
antigen
foreign
pathogen
mv
replic
therebi
robust
humor
cellular
immun
respons
induc
shown
protect
capac
substanti
number
experi
purpos
foreign
antigenencod
gene
clone
addit
transcript
unit
plasmid
base
fulllength
mv
vaccin
strain
genom
turn
use
rescu
recombin
mv
provid
fulllength
viral
rna
genom
respect
antigenom
togeth
protein
compon
viral
ribonucleoprotein
complex
transient
transfect
socal
rescu
cell
infecti
center
form
among
transfect
cell
allow
clonal
isol
singl
recombin
virus
subsequ
amplifi
character
vitro
evalu
immunogen
appropri
preclin
anim
model
vaccin
effect
way
prevent
infecti
diseas
term
safeti
costbenefit
ratio
howev
present
develop
vaccin
point
licens
human
use
take
decad
sometim
proven
hardli
possibl
exemplifi
hiv
pandem
minim
time
vaccin
develop
safe
necessari
develop
strategi
allow
immedi
initi
standard
vaccin
develop
lead
success
safe
candid
vaccin
minim
amount
time
one
strategi
use
wellknown
alreadi
author
vaccin
except
safeti
efficaci
record
platform
present
critic
antigen
pathogen
focu
vaccin
develop
therebi
efficaci
immun
respons
trigger
immun
anim
patient
vaccin
vector
also
addit
present
extra
antigen
one
potenti
vaccin
platform
current
develop
recombin
vaccin
strainderiv
measl
virus
unmodifi
liveattenu
measl
viru
mv
vaccin
strain
effici
replic
vaccin
besid
reveal
excel
safeti
record
humor
cellular
immun
respons
elicit
respons
longlast
protect
therefor
target
erad
measl
use
vaccin
vaccin
manufactur
process
extrem
well
establish
million
dose
gener
quit
easili
quickli
gener
recombin
mv
dna
via
revers
genet
becam
feasibl
allow
robust
express
differ
antigen
outlin
replic
modifi
recombin
mv
vaccin
virus
therebi
gener
robust
immun
respons
vector
foreign
antigen
induc
vaccin
transgen
mvsuscept
ifnar
mice
nonhuman
primat
human
patient
see
tabl
indic
high
effici
system
interestingli
prevaccin
anim
protect
immun
measl
still
amend
vaccin
recombin
mv
sinc
signific
immun
respons
foreign
antigen
still
induc
also
human
proband
level
antibodi
chikungunya
viru
chikv
env
antigen
display
neg
correl
preexist
antibodi
level
mv
vector
backbon
plethora
differ
antigen
variou
virus
one
bacterium
clone
recombin
mv
genom
respect
recombin
virus
alreadi
rescu
project
summar
follow
tabl
tabl
depict
mainli
structur
protein
especi
viral
envelop
glycoprotein
express
antigen
yet
gener
recombin
mvderiv
vaccin
simpli
due
expect
especi
humor
immun
antigen
may
result
neutral
antibodi
protect
capac
howev
vector
system
prove
also
capabl
induc
robust
cellular
immun
respons
moreov
also
secret
cytoplasm
membran
bound
marker
differ
luciferas
gfp
lacz
cellular
protein
carcinoembryon
antigen
cea
express
recombin
mv
demonstr
character
applic
potenti
oncolyt
viru
even
membran
pore
protein
sodium
iodid
symport
ni
three
differ
transgen
cassett
size
potenti
exceed
kb
success
express
recombin
mv
demonstr
gener
versatil
vector
system
target
virus
span
coupl
genera
famili
also
development
stage
differ
vaccin
quit
divers
rang
demonstr
success
antigen
express
recombin
mv
span
demonstr
humor
cellular
immunogen
encod
antigen
demonstr
vaccin
protect
efficaci
appropri
preclin
anim
model
note
recombin
mv
encod
glycoprotein
antigen
chikungunya
viru
mvchikv
alreadi
test
clinic
phase
studi
human
volunt
demonstr
efficaci
appropri
mous
primat
anim
model
recombin
vaccin
deliv
proof
trigger
antigenspecif
immun
respons
immun
determin
measur
total
antibodi
elisa
neutral
antibodi
nab
reactiv
cell
determin
elispot
intracellular
cytokin
stain
ic
c
protect
capac
vaccineinduc
immun
respons
challeng
appropri
anim
model
determin
reduct
pathogen
load
attenu
etiopatholog
principl
safeti
immunogen
human
patient
irrespect
preform
antimeasl
immun
thu
rout
clinic
develop
recombin
mvderiv
vaccin
open
one
hand
recombin
vaccin
may
valuabl
use
primari
measl
vaccin
immun
children
simultan
measl
secondari
pathogen
concern
respect
pediatr
popul
without
need
vaccin
children
two
differ
vaccin
exampl
mv
express
hepat
b
viru
small
antigen
hbsag
may
use
region
high
hbv
preval
protect
children
earli
potenti
chronic
infect
buy
one
get
one
free
strategi
hand
recombin
mv
one
potenti
vaccin
platform
use
fast
track
develop
vaccin
emerg
pathogen
fast
avail
vaccin
may
critic
respect
mvderiv
vaccin
corona
viru
respons
middl
east
respiratori
syndrom
merscov
express
merscov
glycoprotein
among
first
progress
vaccin
candid
evalu
saudi
arabia
ministri
health
fulllength
mv
genom
plasmid
pbrmv
gfp
h
p
poliimv
atu
p
see
note
mv
genom
encod
plasmid
contain
socal
addit
transcript
unit
atu
facilit
insert
foreign
orf
usual
singlecutt
restrict
endonucleas
recognit
site
place
start
stop
signal
atu
mention
exampl
mlui
aatii
see
note
driven
express
plasmid
mv
protein
compon
viral
rnp
complex
ie
nucleocapsid
protein
n
phosphoprotein
p
viral
rnadepend
rnapolymeras
l
pemcna
pemcpa
pemcla
respect
cdna
foreign
antigen
express
recombin
vaccin
orf
flank
mlui
aatii
restrict
site
altern
site
part
atu
genom
length
put
recombin
vaccin
obey
ruleofsix
see
note
cell
cultiv
dmem
supplement
fetal
bovin
serum
mm
lgln
addit
mgml
geneticin
use
rescu
describ
cell
cultur
humidifi
atmospher
contain
co
longer
month
thaw
origin
stock
g
needl
one
vaccin
inject
ml
syring
fine
scale
one
vaccin
inject
gener
gene
segment
encod
desir
foreign
antigen
target
pathogen
may
gener
gene
synthesi
codonoptim
orf
encompass
start
stop
codon
flank
respect
restrict
site
allow
direct
clone
gene
segment
atu
fulllength
mv
genom
plasmid
may
necessari
includ
specif
number
extra
nucleotid
stop
codon
site
obey
ruleofsix
see
note
altern
desir
orf
amplifi
basi
plasmid
cdna
cdna
directli
isol
eventu
revers
transcript
target
pathogen
genom
use
rt
pcr
purpos
specif
primer
design
outlin
depend
exact
structur
atu
orf
amplifi
result
cdna
segment
well
mv
genom
plasmid
treat
respect
restrict
endonucleas
use
follow
standard
reaction
mix
dna
u
per
restrict
enzym
neb
buffer
depend
enzym
use
bsa
requir
appli
enzym
fill
nucleasefre
h
dna
digest
proce
temperatur
requir
respect
enzym
allow
thorough
digest
dna
optim
overnight
desir
segment
purifi
restrict
digest
standard
agaros
gel
electrophoresi
see
note
purifi
genomecontain
plasmid
backbon
antigenorf
contain
insert
ligat
use
standard
ligat
condit
least
tenfold
molar
excess
insert
ng
vector
dna
ng
insert
dna
dna
dilut
buffer
fill
nucleasefre
water
mix
dna
ligat
buffer
seed
cellswel
ml
complet
dmem
sixwel
plate
incub
overnight
see
note
next
day
cell
approx
confluent
bevor
start
transfect
seed
vero
cellswel
ml
complet
dmem
sixwel
plate
incub
overnight
see
note
next
day
cell
approx
confluent
bevor
start
transfect
infect
cell
infect
vaccinia
viru
moi
see
note
min
infect
medium
replac
cell
transfect
transfect
respect
mv
genom
cdna
plasmid
mix
pemcna
pemcpa
emcla
helper
plasmid
transfect
use
commerci
avail
lipofect
method
describ
protocol
use
poliibas
rescu
system
transfect
cell
cultur
examin
syncytia
format
daili
see
note
find
syncytia
pick
outlin
see
subhead
step
syncytia
visibl
day
post
overlay
split
overlay
cultur
passag
cultur
purpos
seed
vero
cm
cell
cultur
dish
ml
complet
dmem
incub
h
aspir
medium
cm
cell
cultur
dish
overlay
wash
ml
pb
detach
cell
incub
ml
trypsinedta
min
complet
detach
check
microscop
stop
trypsin
incub
ad
ml
complet
dmem
suspend
cell
pipet
seed
cell
suspens
prepar
cm
cell
cultur
dish
remain
cell
suspens
transfer
ml
tube
snapfrozen
liquid
nitrogen
min
frozen
cell
suspens
thaw
water
bath
result
cell
debri
pellet
centrifug
g
min
transfer
supernat
cm
cell
cultur
dish
dropwis
incub
overnight
see
note
syncytia
format
wait
one
addit
day
still
syncytia
format
repeat
rescu
cell
suspens
transfer
precool
ml
reaction
tube
centrifug
g
min
remov
cell
debri
protein
contain
supernat
transfer
fresh
precool
ml
reaction
tube
store
frozen
cell
lysat
thaw
ice
western
blot
applic
accord
standard
condit
use
antibodi
recogn
mv
protein
eg
nucleocapsid
protein
standard
infect
anoth
antibodi
recogn
foreign
antigen
allow
assess
proper
antigen
express
recombin
vaccin
four
day
booster
immun
splenozyt
harvest
immun
mice
assess
abund
antigenor
vectorspecif
cell
elispot
intracellular
cytokin
stain
stimul
respect
antigen
peptid
either
follow
standard
protocol
use
commerci
avail
kit
accord
manufactur
instruct
immun
preble
directli
booster
vaccin
postprim
day
booster
vaccin
postboost
blood
taken
mous
sera
separ
assess
abund
vectoror
targetspecif
antibodi
titrat
neutral
titer
total
antibodi
titer
elisa
ifnar
mous
strain
suscept
pathogen
vaccin
direct
vaccin
mice
challeng
subsequ
immun
challeng
reli
establish
infect
protocol
unvaccin
anim
result
symptomat
infect
even
death
therebi
allow
test
protect
capac
vaccin
paramet
cours
diseas
pathogen
load
specif
organ
ass
see
note
exampl
pbrmv
gfp
h
p
poliimv
atu
p
contain
genom
plasmid
rescu
recombin
mv
fulllength
mv
vaccin
strain
genom
pbrmv
gfp
h
deriv
plasmid
backbon
low
copi
express
viral
rna
antigenom
control
wherea
p
poliimv
atu
p
pbluescript
high
copi
backbon
poliidriven
plasmid
contain
fulllength
mv
genom
tend
bit
delic
handl
procedur
therefor
plasmid
highcopi
plasmid
backbon
amplifi
e
coli
wherea
lowcopi
plasmid
amplifi
addit
pay
directli
pick
clone
isol
plasmid
grow
cultur
instead
store
liquid
bacteria
cultur
coloni
plate
mv
genomecontain
plasmid
hour
overnight
altern
bacteria
pellet
store
frozen
plasmid
isol
mv
gene
cassett
flank
conserv
genet
element
repres
start
stop
signal
viral
polymeras
complex
duplic
highli
conserv
intergen
sequenc
new
transcript
unit
insert
virtual
posit
viru
genom
allow
insert
express
foreign
gene
antigen
orf
rel
genom
posit
atu
allow
regul
insert
gene
express
due
transcript
gradient
found
mononegaviral
upstream
atu
cassett
locat
higher
amount
mrna
transcrib
infect
cell
higher
protein
express
howev
encod
gene
product
interfer
mv
replic
high
express
level
encod
antigen
may
detriment
number
nucleotid
mv
genom
exactli
divid
presum
due
one
n
protein
bind
six
nucleotid
also
recombin
genom
obey
rule
otherwis
recombin
viru
rescu
therefor
consid
length
insert
gene
segment
divid
rest
length
segment
remov
genom
clone
gene
cassett
insert
genom
plasmid
therebi
one
make
sure
length
result
fulllength
genom
multipl
due
size
genomecontain
plasmid
approx
kda
voltag
agaros
gel
electrophoresi
restrict
max
v
rescu
mv
especi
use
helper
cell
line
standard
rescu
system
guarante
precis
start
stop
transcrib
antigenom
viral
rna
due
precis
start
transcript
stop
due
specif
termin
signal
conjunct
ribozym
flank
viral
genom
sequenc
effici
rescu
quit
variabl
depend
consider
statu
rescu
cell
moreov
syncytia
format
use
cell
overlay
effici
limit
rescu
effici
especi
viru
variant
limit
fusion
activ
unpublish
observ
vaccinia
viru
driven
rescu
allow
usag
cell
line
may
better
suit
propag
one
specif
mv
variant
depend
qualiti
use
plasmid
poliidriven
viru
rescu
effici
usual
result
recombin
mv
precis
genom
lower
precis
start
stop
poll
ii
transcript
may
allow
complet
viru
genom
line
rule
six
prepar
one
sixwel
plate
requir
rescu
differ
mv
addit
well
use
transfect
control
seal
sixwel
plate
properli
avoid
contamin
cell
recombin
mv
addit
express
gfp
fluoresc
marker
protein
check
gfpexpress
help
fluoresc
microscop
identifi
syncytia
easi
marker
protein
easi
evalu
encod
check
syncytia
format
via
light
microscop
phase
contrast
transfect
control
use
exampl
egfp
express
plasmid
without
mv
cdna
helperplasmid
transfect
describ
mv
cdna
use
anoth
vaccinia
viru
mva
pol
express
one
make
sure
rescu
recombin
mv
separ
co
replic
vaccinia
viru
may
tediou
process
due
labori
method
need
physic
separ
differ
viru
popul
step
seem
slightli
effici
hand
includ
one
addit
freezethaw
cycl
quickfreez
liquid
nitrogen
tube
contain
viru
suspens
store
sever
day
check
thaw
viru
regularli
viru
heat
sensit
incub
viru
lead
significantli
reduc
viru
titer
essenti
slew
cell
cultur
dish
immedi
well
properli
avoid
errat
infect
vero
cell
lead
lower
viru
titer
growth
rate
depend
viru
strain
might
modul
addit
genet
inform
therefor
check
viru
growth
regularli
develop
feel
growth
rate
scratch
cell
edg
cell
cultur
dish
hold
plate
inclin
aspir
medium
includ
cell
debri
mv
vaccin
strain
author
use
human
vaccin
usual
regard
safe
accordingli
handl
condit
recombin
viruseseven
bear
ident
vaccin
strain
genomesmay
handl
condit
depend
local
respons
nation
region
regulatori
author
rare
circumst
singl
recombin
mv
may
place
depend
natur
express
foreign
antigen
tri
remov
medium
complet
follow
note
increas
viru
titer
number
aliquot
modifi
depend
freezerspac
experiment
plan
passag
suffici
infect
one
cm
dish
store
around
five
aliquot
virus
use
experi
normal
slew
plate
gentli
time
incub
slew
plate
vigor
time
incub
experiment
mous
work
carri
complianc
regul
respect
anim
protect
law
mice
sacrif
use
studi
depend
respect
experiment
schedul
efficaci
recombin
vaccin
directli
assess
use
challeng
experi
directli
reveal
protect
abolish
attenu
etiopatholog
absenc
appropri
challeng
quantit
abund
antigenspecif
neutral
antibodi
cell
reactiv
indic
protect
efficaci
recombin
vaccin
